Jason Gotlib Selected Research

Jason Gotlib Research Topics

Disease

52	Neoplasms (Cancer) 04/2024 - 02/2004
32	Systemic Mastocytosis 04/2024 - 10/2005
24	Eosinophilia 03/2024 - 01/2005
21	Primary Myelofibrosis (Myelosclerosis) 10/2023 - 03/2012
14	Pdgfra-Associated Chronic Eosinophilic Leukemia 03/2024 - 04/2004
14	Mastocytosis 03/2024 - 08/2006
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2005
12	Hypereosinophilic Syndrome (Loeffler Endocarditis) 12/2015 - 03/2003
10	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2020 - 10/2003
7	Leukemia 01/2022 - 03/2004
7	Anemia 11/2019 - 11/2006
7	Splenomegaly 01/2018 - 10/2013
6	Mast Cell Activation Disorders (Mast-Cell Disease) 03/2024 - 08/2006
6	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2008
5	Polycythemia Vera 02/2024 - 04/2006
5	Hypersensitivity (Allergy) 01/2022 - 01/2021
5	Blast Crisis (Blast Phase) 12/2020 - 08/2004
5	Thrombocytopenia (Thrombopenia) 11/2019 - 03/2012
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2014 - 04/2004
4	Thrombosis (Thrombus) 12/2022 - 03/2014
4	Thrombocytosis (Thrombocythemia) 01/2022 - 12/2011
4	Myeloproliferative Disorders (Myeloproliferative Disorder) 07/2006 - 01/2005
3	Mast-Cell Leukemia (Leukemia, Mast Cell) 04/2024 - 10/2005
3	Hereditary alpha-tryptasemia syndrome 10/2023 - 11/2021
3	Essential Thrombocythemia 01/2022 - 03/2014
3	BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative) 01/2020 - 09/2013
3	Chronic Neutrophilic Leukemia 01/2020 - 09/2013
2	Philadelphia Chromosome 01/2021 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 12/2014
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 03/2003
2	Multiple Myeloma 09/2018 - 04/2016
2	Lymphoma (Lymphomas) 10/2017 - 01/2017
2	Fever (Fevers) 03/2017 - 04/2014
2	Fatigue 01/2017 - 04/2013
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 02/2010 - 01/2005
1	Cutaneous Mastocytosis 04/2024
1	Leukocytosis (Pleocytosis) 04/2024
1	Polycythemia (Erythrocytosis) 02/2024
1	Fibrosis (Cirrhosis) 10/2023
1	Abnormal Karyotype 01/2023

Drug/Important Bio-Agent (IBA)

21	ruxolitinibIBA 10/2023 - 03/2012
17	Imatinib Mesylate (Gleevec)FDA Link 12/2022 - 03/2003
15	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 12/2022 - 01/2006
12	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2024 - 03/2003
12	Phosphotransferases (Kinase)IBA 01/2017 - 02/2004
11	Tryptases (Tryptase)IBA 04/2024 - 10/2014
10	midostaurinIBA 01/2023 - 10/2005
9	Janus Kinase InhibitorsIBA 10/2022 - 01/2013
8	Tyrosine Kinase InhibitorsIBA 01/2018 - 05/2003
8	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 02/2004
7	avapritinibIBA 06/2023 - 12/2021
6	Janus KinasesIBA 01/2023 - 08/2010
6	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2019 - 08/2006
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 03/2004
5	Janus Kinase 1IBA 01/2018 - 12/2013
4	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2022 - 10/2020
4	CalreticulinIBA 01/2022 - 03/2014
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2014
4	CytokinesIBA 01/2021 - 01/2006
4	Janus Kinase 2IBA 01/2021 - 12/2013
3	Syntex adjuvant formulationIBA 02/2024 - 01/2021
3	Cladribine FDA LinkGeneric 01/2022 - 08/2006
3	Core Binding Factors (Core-Binding Factor)IBA 01/2021 - 01/2018
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 10/2005
3	Thrombopoietin (c-mpl Ligand)IBA 06/2014 - 12/2011
3	Farnesyltranstransferase (Farnesyltransferase)IBA 03/2008 - 01/2005
2	Arthropod VenomsIBA 04/2024 - 01/2022
2	Immunoglobulin E (IgE)IBA 01/2022 - 01/2022
2	Alkaline PhosphataseIBA 01/2021 - 12/2019
2	Azacitidine (5 Azacytidine)FDA Link 11/2020 - 01/2016
2	Hemoglobins (Hemoglobin)IBA 11/2019 - 03/2014
2	Lenalidomide (CC 5013)FDA Link 09/2018 - 01/2016
2	AntibodiesIBA 01/2018 - 12/2015
2	Interferon-alpha (Interferon Alfa)IBA 10/2016 - 08/2006
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2014 - 11/2010
2	Etoposide (VP 16)FDA LinkGeneric 12/2014 - 11/2010
2	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2014 - 11/2010
2	Erythropoietin FDA Link 06/2014 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 11/2013 - 12/2012
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2013 - 01/2009
2	Interleukin-5 (Interleukin 5)IBA 04/2012 - 01/2006
2	Dasatinib (BMS 354825)FDA Link 08/2011 - 08/2006
2	mepolizumabIBA 03/2010 - 02/2010
2	Alemtuzumab (Campath)FDA Link 03/2010 - 02/2010
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2010 - 01/2005
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 02/2010 - 01/2006
2	beta CateninIBA 03/2009 - 08/2004
2	tipifarnib (R115777)IBA 03/2008 - 02/2007
2	Platelet-Derived Growth Factor alpha ReceptorIBA 01/2005 - 03/2003
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2024
1	Penicillins (Penicillin)FDA Link 04/2024
1	pemigatinibIBA 03/2024
1	HepcidinsIBA 02/2024
1	Serum Amyloid P-ComponentIBA 10/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022

Therapy/Procedure

45	Therapeutics 12/2022 - 10/2003
5	Drug Therapy (Chemotherapy) 01/2020 - 11/2010
3	Cell Transplantation 03/2024 - 01/2016
2	Transplantation 03/2024 - 01/2015
2	Hematopoietic Stem Cell Transplantation 01/2017 - 10/2016